Pimozide is metabolised by CYP3A4, which is inhibited by the protease inhibitors. Raised pimozide levels, which increase the risk of potentially fatal arrhythmias, would be expected. Concurrent use is contraindicated.
(16)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.